期刊文献+

小鼠MIP-1α真核表达质粒的构建及在HSV-II核酸疫苗中的应用 被引量:4

Construction of recombinant eukaryotic expression plasmid of murine chemokine MIP-1α and coimmunization with HSV-II DNA vaccine
原文传递
导出
摘要 目的构建小鼠巨噬细胞炎性蛋白-1α(MIP-1α)的真核表达质粒,观察其作为分子佐剂对单纯疱疹病毒II型(HSV-II)DNA疫苗免疫效果的影响。方法以LPS刺激RAW264.7细胞提取总RNA。采用RT-PCR扩增出MIP-1α基因的全部编码序列,利用克隆载体pUCm-T,将其亚克隆入pcDNA3中,构建出小鼠MIP-1α的真核表达质粒Pm;将其转染COS-7细胞,并用Boyden趋化小室法检测MIP-1α的生物学活性。然后用其与HSV-IIgD的DNA疫苗一起免疫BALB/c小鼠,检测免疫小鼠的特异性抗体、脾T细胞增殖反应及病毒攻击小鼠后对小鼠的保护率,观察MIP-1α对HSV-IIDNA疫苗免疫效果的影响。结果成功构建了小鼠MIP-1α的重组真核表达质粒;免疫BALB/c小鼠发现,其作为分子佐剂可加强HSV-IIgDDNA疫苗的免疫效果。结论小鼠MIP-1α可作为HSV-IIgDDNA疫苗的分子佐剂,为研制新型有效的HSV-IIDNA疫苗提供一定的依据。 AIM: To construct the recombinant eukaryotic expression plasmid of murine macrophage inflammatory protein-1α(MIP-1α) and investigate the effect of MIP-1α as an adjuvant on immune response induced by herpes simplex virus type Ⅱ glycoprotein D (HSV-Ⅱ gD) DNA vaccine. METHODS: Using total RNA from RAW204.7 cells stimulated with LPS, the whole code sequence of murine MIP-1α was amplified by reverse transcription polymerase chain reaction(RT-PCR) and inserted into pcDNA3 at Hind Ⅲ/Xba Ⅰ restriction sites. The recombinant eukaryotic expression plasmid Pm was transiently expressed in COS-7 cells and its specificity was demonstrated by RT-PCR and boyden chemotaxis chamber. BALB/c mice were immunized with gD DNA vaccine and/or MIP-1α, and the effect of MIP-1α on gD DNA vaccine was evaluated by detecting anti-HSV-Ⅱ antibody, antigen-specific lymphoproliferative responses, and examining survival rates after mice were challenged intravaginally with HSV-Ⅱ. RESULTS: The recombinant eukaryotic expression plasmid of murine MIP-1α was constructed, and it was revealed that immune responses of HSV-Ⅱ gD DNA vaccine were enhanced by coimmunization with MIP-1α. CONCLUSION: The murine MIP-1α can be used as an adjuvant of HSV-Ⅱ gD DNA vaccine.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2006年第3期286-289,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 小鼠巨噬细胞炎性蛋白-1α(MIP-1α) 单纯疱疹病毒Ⅱ型(HSV-Ⅱ)DNA疫苗 分子佐剂 murine macrophage inflammatory protein-1α(MIP-1α) herpes simplex virus type Ⅱ ( HSV-Ⅱ) DNA vaccine molecular adjuvant
  • 相关文献

参考文献12

  • 1王福祥,孙永涛.细胞因子佐剂对HIV DNA疫苗免疫效果的影响[J].细胞与分子免疫学杂志,2003,19(6):620-622. 被引量:4
  • 2江文正,金宁一,李子健,张立树,王宏,金洪涛.IL-18和HIV-1gag-gp120嵌合基因DNA疫苗联合免疫小鼠的免疫应答[J].细胞与分子免疫学杂志,2004,20(4):433-435. 被引量:7
  • 3Perales MA,Fantuzzi G,Goldberg SM,et al.GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin:implications for DNA vaccine[J].Cytokines Cell Molther,2002,7(3):125-133.
  • 4Bu J,Song Y,Rompato G,et al.Co-delivery of IL-2 or liposome augment the responses of mice to a DNA vaccine for DNA vaccine for pseudorabies virus IE180[J].Comp Immunol Microbiol Infect Dis,2003,26(3):175-187.
  • 5Eo SK,Lee S,Kumaraguru U,et al.Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands[J].Vaccine,2001,19(32):4685 -4693.
  • 6Lu Y,Xin KQ,Hamajima K,et al.Macrophage inflammatoryprotein1alpha(MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1[J].Clin Exp Immunol,1999,115(2):335 -341.
  • 7Kim JJ,Nottingham LK,Sin JI,et al.CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines[J].J Clin Invest,1998,102(6):1112-1124.
  • 8李梅,李晓眠,刘民.单纯疱疹病毒I型Stocker株gD膜外区基因的克隆与序列测定[J].天津医科大学学报,2001,7(2):211-214. 被引量:5
  • 9奥斯伯F 布伦特R 金斯顿RE 等 颜子颖 王海林 编译.精编分子生物学实验指南[M].北京:科学出版社,1998.366-373.
  • 10Alam R,York J,Boyars M,et al.Increased MCP-1,RANTES,and MIP-1 alpha in bronchoalveolar lavage fluid of allergic asthmatic patients[J].Am J Respir Crit Care Med,1996,153(4 Pt 1):1398-1404.

二级参考文献35

  • 1成军 陈菊梅.白细胞介素18的研究进展[J].细胞和分子免疫学杂志,1999,15:1-3.
  • 2[1]Richmond JF, Lu S, Santoro JC, et al. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting[J]. J Virol, 1998, 72(11): 9092-9100.
  • 3[2]Billaut-Mulot O, Idziorek T, Ban E, et al. Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine[J]. Vaccine, 2000, 19(1): 95-102.
  • 4[3]Billaut-Mulot O, Idziorek T, Loyens M, et al. Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost[J]. Vaccine, 2001, 19(20-22): 2803-2811.
  • 5[4]Allen TM, Mortara L, Mothe BR, et al. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication[J]. J Virol, 2002, 76(8): 4108- 4112.
  • 6[5]Kim JJ, Yang JS, Manson KH, et al. Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL- 4 gene adjuvants[J]. Vaccine, 2001, 19(17-19): 2496-2505.
  • 7[6]Barouch DH, Santra S, Steenbeke TD, et al. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration[J]. J Immunol, 1998, 161(4): 1875-1882.
  • 8[7]Barouch DH, Craiu A, Kuroda MJ, et al. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys[J]. Proc Natl Acad Sci USA, 2000, 97(8): 4192- 4197.
  • 9[8]Barouch DH, Santra S, Schmitz JE, et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination[J]. Science, 2000, 290(5491): 486- 492.
  • 10[9]Kim JJ, Nottingham LK, Tsai A, et al. Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants[J]. J Med Primatol, 1999, 28(4-5): 214-223.

共引文献167

同被引文献50

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部